本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Viridian Therapeutics, Inc.

27.39
-0.8100-2.87%
盤後27.30-0.0900-0.33%19:27 EDT
成交量:141.35萬
成交額:3,908.65萬
市值:27.99億
市盈率:-8.24
高:28.19
開:27.86
低:27.29
收:28.20
52周最高:34.29
52周最低:9.90
股本:1.02億
流通股本:1.02億
量比:0.69
換手率:1.39%
股息:- -
股息率:- -
每股收益(TTM):-3.3245
每股收益(LYR):-3.3245
淨資產收益率:-49.16%
總資產收益率:-27.67%
市淨率:4.74
市盈率(LYR):-8.24

資料載入中...

2025/05/06

重要事件披露

Form 8-K - Current report
2025/04/07

重要事件披露

Form 8-K - Current report
2025/03/10

重要事件披露

Form 8-K - Current report
2025/03/04

重要事件披露

Form 8-K - Current report
2025/03/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/16

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/18

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/17

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/10

重要事件披露

Form 8-K - Current report
2024/08/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans